| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.002 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.003 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |